Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to include a new vulnerability disclosure section and has revised its version number to v2.16.8, while removing outdated dates and the previous version number v2.16.6.
    Difference
    1%
    Check dated 2025-07-27T14:28:06.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.6%
    Check dated 2025-07-20T06:53:23.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    0.7%
    Check dated 2025-07-13T05:55:46.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.7%
    Check dated 2025-07-06T00:15:09.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov data ingest modernization has been rescheduled to July 2025, and the study GLORIOSA has been updated with new details regarding its design and locations, including a significant increase in the number of participating sites.
    Difference
    100%
    Check dated 2025-06-28T22:04:10.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.2 to v2.16.3.
    Difference
    0.4%
    Check dated 2025-06-14T12:51:30.000Z thumbnail image

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.